| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |